Botulinum Antitoxin Heptavalent (2026)
UKHSA is inviting suppliers to participate in a preliminary market engagement exercise for Botulinum Antitoxin Heptavalent (HBAT) through this Request for Information (RFI), in accordance with the Procurement Act 2023. The purpose of this exercise is to gather information on available products, supplier capability, and market conditions to inform a potential future procurement.
Buyer
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Value
£1
Published
26 Jun 2026
Closes
17 Jul 2026
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Botulinum Antitoxin Heptavalent (2026)
Lot 1
Value not provided
Delivery: UK · United Kingdom
Document metadata
Preliminary market engagement notice on Find a Tender
Preliminary market engagement notice on Find a Tender
marketEngagementNotice · UK2 · text/html
26 Jun 2026
Unlock document link